Company / Working Capital per Share
4D Molecular Therapeutics, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$8.06
FY2025
5-year range
$6.35 / $9.42
FY2021-FY2025
Trend
-14.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $8.51 to $8.06 over the past 2 years.
Based on SEC 10-K filings.
8.06 in FY2025 with a 5-year CAGR of -30.9%.
Declined from $8.51 to $8.06 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +8.3%
- 5-Year CAGR
- -30.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 14.4% year-over-year.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.06 | -14.4% |
| FY2024 | $9.42 | +10.7% |
| FY2023 | $8.51 | +33.9% |
| FY2022 | $6.35 | -29.3% |
| FY2021 | $8.99 | -82.5% |
| FY2020 | $51.34 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026